Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease–specific disability

J Beaudreuil, A Allard, D Zerkak… - Arthritis care & …, 2011 - Wiley Online Library
Objective To our knowledge, no functional outcome measure has been developed and
validated for Dupuytren's disease. We aimed to develop and validate a patient‐reported …

Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial.

…, P Ravaud, K Champion, E Dernis, D Zerkak… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: To evaluate the effect on health and functional status of an 8-week group-education
program for rheumatoid arthritis (RA) in addition to usual medical care. METHODS: All …

Influence of patient education on exercise compliance in rheumatoid arthritis: a prospective 12-month randomized controlled trial.

…, P Ravaud, K Champion, E Dernis, D Zerkak… - The Journal of …, 2008 - jrheum.org
OBJECTIVE: To determine the effect of education on the exercise habits of patients with
rheumatoid arthritis (RA) after 6 and 12 months. METHODS: We studied 208 outpatients …

Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?

M Soubrier, D Zerkak, L Gossec, X Ayral… - The Journal of …, 2006 - jrheum.org
OBJECTIVE:To determine in clinical practice which clinical status variables for rheumatoid
arthritis (RA) are most closely associated with a change in disease modifying antirheumatic …

Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.

M Soubrier, D Zerkak, M Dougados - The Journal of Rheumatology, 2006 - jrheum.org
OBJECTIVE: To evaluate the prevalence of patients with rheumatoid arthritis (RA) in whom
lowering low density lipoprotein cholesterol (LDL-C) should be considered in accord with the …

Atteinte rachidienne isolée au cours d'une dysplasie fibreuse

AM Avimadje, P Goupille, D Zerkak, G Begnard… - Revue du …, 2000 - Elsevier
L'atteinte rachidienne isolée de la dysplasie fibreuse est très rare. Nous rapportons l'observation
d'une patiente de 61 ans aux antécédents de lombosciatiques récidivantes depuis l'…

The use of glucosamine therapy in osteoarthritis

D Zerkak, M Dougados - Current rheumatology reports, 2004 - Springer
Glucosamine products have been used extensively for the management of pain in
osteoarthritis. This paper reviews the most recent clinical and experimental studies regarding its …

Monostotic fibrous dysplasia of the lumbar spine.

AM Avimadje, P Goupille, D Zerkak, G Begnard… - Joint Bone …, 2000 - europepmc.org
Monostotic fibrous dysplasia is exceedingly rare. We report a case in a 61-year-old woman
with a history of recurrent low back pain and sciatica since 35 years of age. While walking, …

Mécanismes physiopathologiques des arthrites septiques

D Zerkak, JM Ziza, N Desplaces - Revue du rhumatisme, 2006 - Elsevier
Conclusion L'interaction entre les facteurs de virulence des bactéries et les défenses de l'hôte
détermine l'initiation et la prolongation de l'infection articulaire et des lésions …

Validation of the general health questionnaire 12 for assessing psychological distress in patients with chronic low back pain

J Beaudreuil, D Zerkak, JC Metivier… - Journal of Back and …, 2022 - content.iospress.com
BACKGROUND: The General Health Questionnaire 12 (GHQ-12) is a short easy-to-use
scale to assess psychological distress. The GHQ-12 has not been validated for assessing …